Back to Search Results
Image Place holder

Juan Hernandez Prera, MD

 
Specialty: Pathology
Program: Pathology

Call 1-888-663-3488

Call 1-888-663-3488


Locations:
Overview

Cancer Focus: Adrenal Carcinoma, Head and Neck Cancer, Oral Cavity or Throat Cancer, Thyroid Cancer

Dr. Juan Carlos Hernandez-Prera is an Assistant Member in Anatomic Pathology at Moffitt Cancer Center. Dr. Hernandez-Prera received his MD from Universidad Francisco Marroquín, Guatemala. He completed an Anatomic Pathology Residency and a Fellowship in Head and Neck and Endocrine Pathology in the Department of Pathology at The Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York. Dr. Hernandez-Prera most recently was an Assistant Professor at Icahn School of Medicine at Mount Sinai and Attending Pathologist at Mount Sinai Beth Israel, New York. Dr. Hernandez-Prera is a board-certified anatomic pathologist with expertise in the subspecialty of Head and Neck/Endocrine Pathology. His research focus is analysis of the clinical, pathological, immunohistochemical, molecular and cytogenetic features of Head and Neck/Endocrine tumors. He is interested in identifying novel biomarkers that will help guide translation into new diagnostic, therapeutic and prognostic tools. He aims to bridge classical histomorphology with molecular advances to better characterize Head and Neck/Endocrine tumors.


Education & Training

Fellowship:

  • Mount Sinai Hospital Icahn School of Medicine - Head & Neck and Endocrine Pathology

Residency:

  • Mount Sinai Hospital Icahn School of Medicine - Pathology

Medical School:

  • Universidad Francisco Marroquin - MD
Participating Trials

If you believe you are eligible for one of these trials or studies, please call
813-745-6100 or toll-free 1-800-679-0775.

Publications

  • Patel KB, Padhya TA, Huang J, Hernandez-Prera JC, Li T, Chung CH, Wang L, Wang X. Plasma cell-free DNA methylome profiling in pre- and post-surgery oral cavity squamous cell carcinoma. Mol Carcinogen. 2023 Apr.62(4):493-502. Pubmedid: 36636912. Pmcid: PMC10023468.
  • McLean-Holden AC, Rooper LM, Lubin DJ, Magliocca KR, Manucha V, Sadow PM, Tobias J, Vargo RJ, Thompson LDR, Heidarian A, Weinreb I, Wenig B, Gagan J, Hernandez-Prera JC, Bishop JA. Frankly Invasive Carcinoma Ex-intraductal Carcinoma: Expanding on an Emerging and Perplexing Concept in Salivary Gland Tumor Pathology. Head Neck Pathol. 2022 Sep.16(3):657-669. Pubmedid: 34985683. Pmcid: PMC9424381.
  • Hellquist H, Agaimy A, Stenman G, Franchi A, Nadal A, Skalova A, Leivo I, Zidar N, Simpson RHW, Slootweg PJ, Hernandez-Prera JC, Ferlito A. Development of head and neck pathology in Europe. Virchows Arch. 2022 May.480(5):951-965. Pubmedid: 35028711.
  • Hernandez-Prera JC. Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: The Neck and Lymph Nodes, Metastasis, and Melanocytic Tumors. Head Neck Pathol. 2022 Mar.16(1):110-122. Pubmedid: 35312983. Pmcid: PMC9018916.
  • Hernandez-Prera JC, Saeed-Vafa D, Heidarian A, Gewandter K, Otto K, Wenig BM. Sclerosing Polycystic Adenoma: Conclusive Clinical and Molecular Evidence of Its Neoplastic Nature. Head Neck Pathol. 2022 Jun.16(2):416-426. Pubmedid: 34410594. Pmcid: PMC9187789.
  • Chung CH, Li J, Steuer CE, Bhateja P, Johnson M, Masannat J, Poole MI, Song F, Hernandez-Prera JC, Molina H, Wenig BM, Kumar S, Kuperwasser C, Stephens PJ, Farinhas JM, Shin DM, Kish JA, Muzaffar J, Kirtane K, Rocco JW, Schell MJ, Saba NF, Bonomi M. Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2022 Jun.28(11):2329-2338. Pubmedid: 35344035. Pmcid: PMC9167762.
  • Heidarian A, Wenig BM, Hernandez-Prera JC. Evaluation of programmed death ligand 1 immunohistochemistry in cytology specimens of head and neck squamous cell carcinoma. Cancer Cytopathol. 2022 Feb.130(2):91-95. Pubmedid: 34411441.
  • de Bree R, de Keizer B, Civantos FJ, Takes RP, Rodrigo JP, Hernandez-Prera JC, Halmos GB, Rinaldo A, Ferlito A. What is the role of sentinel lymph node biopsy in the management of oral cancer in 2020?. Eur Arch Otorhinolaryngol. 2021 Sep.278(9):3181-3191. Pubmedid: 33369691. Pmcid: PMC8328894.
  • Hernandez-Prera JC, Skálová A, Franchi A, Rinaldo A, Vander Poorten V, Zbären P, Ferlito A, Wenig BM. Pleomorphic adenoma: the great mimicker of malignancy. Histopathology. 2021 Sep.79(3):279-290. Pubmedid: 33368685.
  • Hernandez-Prera JC. Molecular Pathology of Thyroid Tumors: Old Problems and New Concepts. Surg Pathol Clin. 2021 Sep.14(3):493-506. Pubmedid: 34373098.
  • de la Iglesia JV, Slebos RJC, Martin-Gomez L, Wang X, Teer JK, Tan AC, Gerke TA, Aden-Buie G, van Veen T, Masannat J, Chaudhary R, Song F, Fournier M, Siegel EM, Schabath MB, Wadsworth JT, Caudell J, Harrison L, Wenig BM, Conejo-Garcia J, Hernandez-Prera JC, Chung CH. Correction: Effects of Tobacco Smoking On the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2021 Sep.27(17):4941. Pubmedid: 34470812.
  • Franchi A, Thompson LDR, Hernandez-Prera JC, Agaimy A, Williams MD, Mikkelsen LH, Bishop JA, Willems SM, Hellquist H, Ferlito A. Emerging Entities and New Diagnostic Markers for Head and Neck Soft Tissue and Bone Tumors. Adv Anat Pathol. 2021 May.28(3):139-149. Pubmedid: 33559990.
  • Skalova A, Leivo I, Hellquist H, Agaimy A, Simpson RHW, Stenman G, Vander Poorten V, Bishop JA, Franchi A, Hernandez-Prera JC, Slouka D, Willems SM, Olsen KD, Ferlito A. High-grade Transformation/Dedifferentiation in Salivary Gland Carcinomas: Occurrence Across Subtypes and Clinical Significance. Adv Anat Pathol. 2021 May.28(3):107-118. Pubmedid: 33825717.
  • Sanabria A, Zafereo M, Thompson LDR, Hernandez-Prera JC, Kowalski LP, Nixon IJ, Shaha A, Rodrigo JP, Mäkitie A, Poorten VV, Suarez C, Zbären P, Rinaldo A, Ferlito A. Frozen section in thyroid gland follicular neoplasms: It's high time to abandon it!. Surg Oncol. 2021 Mar.36:76-81. Pubmedid: 33316682.
  • Chung CH, Bonomi M, Steuer CE, Li J, Bhateja P, Johnson M, Masannat J, Song F, Hernandez-Prera JC, Wenig BM, Molina H, Farinhas JM, McMullen CP, Wadsworth JT, Patel KB, Kish JA, Muzaffar J, Kirtane K, Rocco JW, Schell MJ, Saba NF. Concurrent Cetuximab and Nivolumab as a Second-Line or beyond Treatment of Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results of Phase I/II Study. Cancers (Basel). 2021 Mar.13(5). Pubmedid: 33803335. Pmcid: PMC7967147.
  • Skalova A, Leivo I, Hellquist H, Agaimy A, Simpson RHW, Stenman G, Vander Poorten V, Bishop JA, Franchi A, Hernandez-Prera JC, Slouka D, Willems SM, Olsen KD, Ferlito A. High-grade Transformation/Dedifferentiation in Salivary Gland Carcinomas: Occurrence Across Subtypes and Clinical Significance. Adv Anat Pathol. 2021 Mar. Pubmedid: 34009780.
  • Hernandez-Prera J, Valderrabano P, Creed J, de la Iglesia JV, Slebos R, Centeno BA, Tarasova V, Hallanger-Johnson J, Veloski C, Otto KJ, Wenig BM, Yoder S, Lam C, Park DS, Anderson AR, Raghunand N, Berglund A, Caudell J, Gerke TA, Chung CH. Molecular Determinants of Thyroid Nodules with Indeterminate Cytology and RAS Mutations. Thyroid. 2021 Jan.31(1):36-49. Pubmedid: 32689909. Pmcid: PMC7864115.
  • Chaudhary R, Slebos RJC, Song F, McCleary-Sharpe KP, Masannat J, Tan AC, Wang X, Amaladas N, Wu W, Hall GE, Conejo-Garcia JR, Hernandez-Prera JC, Chung CH. Effects of checkpoint kinase 1 inhibition by prexasertib on the tumor immune microenvironment of head and neck squamous cell carcinoma. Mol Carcinogen. 2021 Feb.60(2):138-150. Pubmedid: 33378592. Pmcid: PMC7856233.
  • Quer M, Hernandez-Prera JC, Silver CE, Casasayas M, Simo R, Vander Poorten V, Guntinas-Lichius O, Bradley PJ, Tong-Ng W, Rodrigo JP, Mäkitie AA, Rinaldo A, Kowalski LP, Sanabria A, de Bree R, Takes RP, López F, Olsen KD, Shaha AR, Ferlito A. Current Trends and Controversies in the Management of Warthin Tumor of the Parotid Gland. Diagnostics (Basel). 2021 Aug.11(8). Pubmedid: 34441400. Pmcid: PMC8391156.
  • López F, Mäkitie A, de Bree R, Franchi A, de Graaf P, Hernández-Prera JC, Strojan P, Zidar N, Strojan Fležar M, Rodrigo JP, Rinaldo A, Centeno BA, Ferlito A. Qualitative and Quantitative Diagnosis in Head and Neck Cancer. Diagnostics (Basel). 2021 Aug.11(9). Pubmedid: 34573868. Pmcid: PMC8466857.
  • Rodrigo JP, Sánchez-Canteli M, López F, Wolf GT, Hernández-Prera JC, Williams MD, Willems SM, Franchi A, Coca-Pelaz A, Ferlito A. Tumor-Infiltrating Lymphocytes in the Tumor Microenvironment of Laryngeal Squamous Cell Carcinoma: Systematic Review and Meta-Analysis. Biomedicines. 2021 Apr.9(5). Pubmedid: 33925205. Pmcid: PMC8145951.
  • Hernandez-Prera JC. The evolving concept of aggressive histological variants of differentiated thyroid cancer. Semin Diagn Pathol. 2020 Sep.37(5):228-233. Pubmedid: 32241577.
  • Civantos FJ, Vermorken JB, Shah JP, Rinaldo A, Suárez C, Kowalski LP, Rodrigo JP, Olsen K, Strojan P, Mäkitie AA, Takes RP, de Bree R, Corry J, Paleri V, Shaha AR, Hartl DM, Mendenhall W, Piazza C, Hinni M, Robbins KT, Tong NW, Sanabria A, Coca-Pelaz A, Langendijk JA, Hernandez-Prera J, Ferlito A. Metastatic Squamous Cell Carcinoma to the Cervical Lymph Nodes From an Unknown Primary Cancer: Management in the HPV Era. Front Oncol. 2020 Nov.10:593164. Pubmedid: 33244460. Pmcid: PMC7685177.
  • de la Iglesia JV, Slebos RJ, Martin-Gomez L, Wang X, Teer JK, Tan AC, Gerke TA, Aden-Buie G, Van Veen T, Masannat J, Chaudhary R, Song F, Fournier M, Siegel EM, Schabath MB, Wadsworth JT, Caudell JJ, Harrison LB, Wenig B, Conejo-Garcia JR, Hernandez-Prera JC, Chung CH. Effects of Tobacco Smoking on the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2020 Mar.26(6):1474-1485. Pubmedid: 31848186. Pmcid: PMC7073297.
  • Rodrigo JP, Hernandez-Prera JC, Randolph GW, Zafereo ME, Hartl DM, Silver CE, Suárez C, Owen RP, Bradford CR, Mäkitie AA, Shaha AR, Bishop JA, Rinaldo A, Ferlito A. Parathyroid cancer: An update. Cancer Treat Rev. 2020 Jun.86:102012. Pubmedid: 32247225.
  • Hellquist H, Ferlito A, Mäkitie AA, Thompson LDR, Bishop JA, Agaimy A, Hernandez-Prera JC, Gnepp DR, Willems SM, Slootweg PJ, Rinaldo A. Developing Classifications of Laryngeal Dysplasia: The Historical Basis. Adv Ther. 2020 Jun.37(6):2667-2677. Pubmedid: 32329013. Pmcid: PMC7467449.
  • Coca-Pelaz A, Shah JP, Hernandez-Prera JC, Ghossein RA, Rodrigo JP, Hartl DM, Olsen KD, Shaha AR, Zafereo M, Suarez C, Nixon IJ, Randolph GW, Mäkitie AA, Kowalski LP, Vander Poorten V, Sanabria A, Guntinas-Lichius O, Simo R, Zbären P, Angelos P, Khafif A, Rinaldo A, Ferlito A. Papillary Thyroid Cancer-Aggressive Variants and Impact on Management: A Narrative Review. Adv Ther. 2020 Jul.37(7):3112-3128. Pubmedid: 32488657. Pmcid: PMC7467416.
  • Chaudhary R, Wang X, Cao B, De La Iglesia J, Masannat J, Song F, Hernandez-Prera JC, Gimbrone NT, Slebos RJ, Chung CH. Long noncoding RNA, LINC00460, as a prognostic biomarker in head and neck squamous cell carcinoma (HNSCC). Am J Transl Res. 2020 Feb.12(2):684-696. Pubmedid: 32194915. Pmcid: PMC7061833.
  • Gale N, Cardesa A, Hernandez-Prera JC, Slootweg PJ, Wenig BM, Zidar N. Laryngeal Dysplasia: Persisting Dilemmas, Disagreements and Unsolved Problems-A Short Review. Head Neck Pathol. 2020 Dec.14(4):1046-1051. Pubmedid: 32141027. Pmcid: PMC7669915.
  • Almangush A, Mäkitie AA, Triantafyllou A, de Bree R, Strojan P, Rinaldo A, Hernandez-Prera JC, Suárez C, Kowalski LP, Ferlito A, Leivo I. Staging and grading of oral squamous cell carcinoma: An update. Oral Oncol. 2020 Aug.107:104799. Pubmedid: 32446214.
  • Na K, Hernandez-Prera JC, Lim JY, Woo HY, Yoon SO. Characterization of novel genetic alterations in salivary gland secretory carcinoma. Mod Pathol. 2020 Apr.33(4):541-550. Pubmedid: 31822803. Pmcid: PMC7113190.
  • Sridharan S, Thompson LDR, Purgina B, Sturgis CD, Shah AA, Burkey B, Tuluc M, Cognetti D, Xu B, Higgins K, Hernandez-Prera JC, Guerrero D, Bundele MM, Kim S, Duvvuri U, Ferris RL, Gooding WE, Chiosea SI. Early squamous cell carcinoma of the oral tongue with histologically benign lymph nodes: A model predicting local control and vetting of the eighth edition of the American Joint Committee on Cancer pathologic T stage. Cancer. 2019 Sep.125(18):3198-3207. Pubmedid: 31174238. Pmcid: PMC7723468.
  • Strosberg C, Ferlito A, Triantafyllou A, Gnepp DR, Bishop JA, Hellquist H, Strojan P, Willems SM, Stenman G, Rinaldo A, Hernandez-Prera JC. Update on Neuroendocrine Carcinomas of the Larynx. Am J Clin Pathol. 2019 Nov.152(6):686-700. Pubmedid: 31415081.
  • Hernandez-Prera JC, Holmes BJ, Valentino A, Harshan M, Bacchi CE, Petersson F, Liu KK, Najfeld V, Wenig BM. Macrocystic (Mammary Analogue) Secretory Carcinoma: An Unusual Variant and a Pitfall in the Differential Diagnosis of Cystic Lesions in the Head and Neck. Am J Surg Pathol. 2019 Nov.43(11):1483-1492. Pubmedid: 31464708.
  • Martin-Gomez L, Giuliano AR, Fulp WJ, Caudell J, Echevarria M, Sirak B, Abrahamsen M, Isaacs-Soriano KA, Hernandez-Prera JC, Wenig BM, Vorwald K, McMullen CP, Wadsworth JT, Slebos RJ, Chung CH. Human Papillomavirus Genotype Detection in Oral Gargle Samples Among Men With Newly Diagnosed Oropharyngeal Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2019 May.145(5):460-466. Pubmedid: 30920604. Pmcid: PMC6537790.
  • Prajapati S, Hernandez-Prera JC. Putting All the Pieces Together: Clinical, Macroscopic and Microscopic Characteristics of Subacute Thyroiditis. Head Neck Pathol. 2019 Jun.13(2):231-234. Pubmedid: 29427032. Pmcid: PMC6514204.
  • McMullen C, Chung CH, Hernandez-Prera JC. Evolving role of human papillomavirus as a clinically significant biomarker in head and neck squamous cell carcinoma. Expert Rev Mol Diagn. 2019 Jan.19(1):63-70. Pubmedid: 30575409.
  • Moubayed SP, Machado R, Tuttle RM, Orloff LA, Randolph G, Hernandez-Prera JC, Griffin MJ, Urken ML. Enhanced interdisciplinary communication: development of an interactive thyroid nodule/cancer disease map. Laryngoscope. 2019 Jan.129(1):269-274. Pubmedid: 30194697.
  • Hellquist H, Paiva-Correia A, Vander Poorten V, Quer M, Hernandez-Prera JC, Andreasen S, Zbären P, Skalova A, Rinaldo A, Ferlito A. Analysis of the Clinical Relevance of Histological Classification of Benign Epithelial Salivary Gland Tumours. Adv Ther. 2019 Aug.36(8):1950-1974. Pubmedid: 31209701. Pmcid: PMC6822986.
  • Strojan P, Hernandez-Prera JC, Beitler JJ, Eisbruch A, Saba NF, Mendenhall WM, Nieto CS, Smee R, Rinaldo A, Ferlito A. Small cell and large cell neuroendocrine carcinoma of the larynx: A comparative analysis. Cancer Treat Rev. 2019 Aug.78:42-51. Pubmedid: 31437725.
  • Hernandez-Prera JC. Historical Evolution of the Polymorphous Adenocarcinoma. Head Neck Pathol. 2018 Sep.13(3):415-422. Pubmedid: 30187348. Pmcid: PMC6684715.
  • Rowe ME, Ozbek U, Machado RA, Yue LE, Hernandez-Prera JC, Valentino A, Qazi M, Brandwein-Weber M, Liu X, Wenig BM, Urken ML. The Prevalence of Extranodal Extension in Papillary Thyroid Cancer Based on the Size of the Metastatic Node: Adverse Histologic Features Are Not Limited to Larger Lymph Nodes. Endocr Pathol. 2018 Mar.29(1):80-85. Pubmedid: 29396810.
  • Moubayed SP, Machado R, Osorio M, Khorsandi A, Hernandez-Prera J, Urken ML. Metastatic squamous cell carcinoma to the superior cervical ganglion mimicking a retropharyngeal lymph node. Am J Otolaryngol. 2018 Jul.38(6):720-723. Pubmedid: 28844495.
  • Hernandez-Prera JC, Kwan R, Tripodi J, Chiosea S, Cordon-Cardo C, Najfeld V, Demicco EG. Reappraising hyalinizing clear cell carcinoma: A population-based study with molecular confirmation. Head Neck. 2017 Mar.39(3):503-511. Pubmedid: 27898192.
  • Machado RA, Moubayed SP, Khorsandi A, Hernandez-Prera JC, Urken ML. Intermittent facial spasms as the presenting sign of a recurrent pleomorphic adenoma. World J Clin Oncol. 2017 Feb.8(1):86-90. Pubmedid: 28246588. Pmcid: PMC5309717.
  • Hernandez-Prera J, Machado R, Asa SL, Baloch ZW, Faquin WC, Ghossein R, LiVolsi VA, Lloyd RV, Mete O, Nikiforov YE, Seethala R, Suster S, Thompson LDR, Turk A, Sadow PM, Urken ML, Wenig BM. Pathologic Reporting of Tall-Cell Variant of Papillary Thyroid Cancer: Have We Reached a Consensus?. Thyroid. 2017 Dec.27(12):1498-1504. Pubmedid: 29020884.
  • Prabhu AV, Sturgis CD, Lai C, Maxwell JH, Merzianu M, Hernandez-Prera JC, Purgina B, Thompson LDR, Tuluc M, Yang X, Seethala RR, Ferris RL, Chiosea SI. Improving margin revision: Characterization of tumor bed margins in early oral tongue cancer. Oral Oncol. 2017 Dec.75:184-188. Pubmedid: 29074194. Pmcid: PMC5774620.
  • Osorio M, Moubayed SP, Hernandez-Prera J, Scott JC, Urken ML. Primary mucosal melanoma of the palatine tonsil: Report of a case and review of the literature. Am J Otolaryngol. 2017 Apr.38(4):501-504. Pubmedid: 28449824.
  • Govindaraj S, Iloreta AM, Tong CC, Hernandez-Prera JC. Evaluation of Patients with Sinonasal and Ventral Skull Base Malignancies. Otolaryng Clin N Am. 2017 Apr.50(2):221-244. Pubmedid: 28314398.
  • Likhterov I, Osorio M, Moubayed SP, Hernandez-Prera JC, Rhodes R, Urken ML. The Ethical Implications of the Reclassification of Noninvasive Follicular Variant Papillary Thyroid Carcinoma. Thyroid. 2016 Sep.26(9):1167-1172. Pubmedid: 27480127.
  • Madrigal E, Prajapati S, Hernandez-Prera JC. Introducing a Virtual Reality Experience in Anatomic Pathology Education. Am J Clin Pathol. 2016 Oct.146(4):462-468. Pubmedid: 27594429.
  • Capo JA, Moubayed D, Moubayed SP, Hernandez-Prera JC, Khorsandi A, Buchbinder D, Urken ML. Pediatric Myofibroma of the Palate with Ulceration and Bone Destruction. Case Rep Otolaryngol. 2016 May.2016:1432764. Pubmedid: 27403363. Pmcid: PMC4923519.
  • Haser GC, Su HK, Hernandez-Prera JC, Khorsandi AS, Wang BY, Urken ML. Pediatric odontogenic fibromyxoma of the mandible: Case report and review of the literature. Head Neck. 2016 Jan.38(1):E25-E28. Pubmedid: 25898806.
  • Saini AT, Hernandez-Prera JC, Teng MS. Pyriform sinus soft-tissue mass recurring in esophagus after excision. JAMA Otolaryngol Head Neck Surg. 2015 Jun.141(6):573-574. Pubmedid: 25856625.
  • Castain C, Sempoux C, Brunt EM, Causse O, Heitzmann A, Hernandez-Prera JC, Le Bail B, Schirmacher P, Thung SN, Balabaud C, Bioulac-Sage P. Coexistence of inflammatory hepatocellular adenomas with HNF1α-inactivated adenomas: is there an association?. Histopathology. 2014 May.64(6):890-895. Pubmedid: 24236804.
  • Hernandez-Prera JC, Polydorides AD. Colitis cystica profunda indefinite for dysplasia in Crohn disease: a potential diagnostic pitfall. Pathol Res Pract. 2014 Dec.210(12):1075-1078. Pubmedid: 25307411.
  • Chang CY, Hernandez-Prera JC, Roayaie S, Schwartz M, Thung SN. Changing epidemiology of hepatocellular adenoma in the United States: review of the literature. Int J Hepatol. 2013 Jan.2013:604860. Pubmedid: 23509632. Pmcid: PMC3595661.
  • Balabaud C, Al-Rabih WR, Chen PJ, Evason K, Ferrell L, Hernandez-Prera JC, Huang SF, Longerich T, Park YN, Quaglia A, Schirmacher P, Sempoux C, Thung SN, Torbenson M, Wee A, Yeh MM, Yeh SH, Le Bail B, Zucman-Rossi J, Bioulac-Sage P. Focal Nodular Hyperplasia and Hepatocellular Adenoma around the World Viewed through the Scope of the Immunopathological Classification. Int J Hepatol. 2013 Apr.2013:268625. Pubmedid: 23691331. Pmcid: PMC3654480.
  • Ko HM, Hernandez-Prera JC, Zhu H, Dikman SH, Sidhu HK, Ward SC, Thung SN. Morphologic features of extrahepatic manifestations of hepatitis C virus infection. Clin Dev Immunol. 2012 Jun.2012:740138. Pubmedid: 22919404. Pmcid: PMC3420144.
  • Hernandez-Prera JC, Polydorides AD. Anisakidosis of the sigmoid colon disguising as metastatic carcinoma: a case report and review of the literature. Pathol Res Pract. 2012 Jul.208(7):433-435. Pubmedid: 22658479.
  • Weissferdt A, Hernandez JC, Kalhor N, Moran CA. Spindle cell thymomas: an immunohistochemical study of 30 cases. Appl Immunohistochem Mol Morphol. 2011 Jul.19(4):329-335. Pubmedid: 21386704.
  • Barnoya J, Arvizu M, Jones MR, Hernandez JC, Breysse PN, Navas-Acien A. Secondhand smoke exposure in bars and restaurants in Guatemala City: before and after smoking ban evaluation. Cancer Causes Control. 2011 Jan.22(1):151-156. Pubmedid: 21046446.

Patient Comments
Overall Satisfaction
0
★★★★★
★★★★★

0 patients rated this provider

The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. These surveys assess the experience of our patients when visiting us for an Outpatient Clinic, Urgent Care or Virtual Health (Telemedicine) visit. Responses are measured on a scale of 1 to 5 with 5 being the best score.

Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Learn more about our patient satisfaction survey

Comments ()

Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.

We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.

Not all providers will have a star rating or comments. In order to ensure accuracy of our ratings, we only display ratings for providers who have a minimum of 30 completed from the previous 12 months.

Learn more about our patient comments

Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:

  • The provider has not yet received the minimum number of patient satisfaction surveys to be eligible for display. We require a minimum of 30 surveys before we post results to ensure that the rating is statistically reliable and a true reflection of patient satisfaction.
  • He or she may be a researcher or other type of provider that does not see patients.
  • The provider practices in a specialty or office that does not use the specified surveys currently used for these ratings.
Learn more about our patient satisfaction survey, ratings and comments